Site Navigation Links

Proto Nazca Hummingbird Fringe

About Me

Henry Glick, Ph.D.

Emeritus Professor of Medicine, University of Pennsylvania

I have more than 35 years of experience in conducting economic assessments of medical therapies. I specialize in economic assessments conducted as part of clinical trials. In addition, I have extensive experience with decision analysis, preference assessment, analysis of observational data, and the evaluation of diagnostic tests. I served on both the first and second ISPOR Randomized Clinical Trial-Cost Effectiveness Analysis (RCT-CEA) Task Forces and on ISPOR’s Task Force on Good Research Practices on Transferability of Economic Data in Health Technology Assessment. For many years I co-taught “Clinical Economics and Clinical Decision Making†as part of the University of Pennsylvania Masters of Clinical Epidemiology program in the Perelman School of Medicine and “Cost Benefit and Cost Effectiveness Analysis in Healthcare†as part of the Ph.D. program in Wharton’s Health Care Systems Department. I have also previously taught a Pharmacoeconomics course at the Food and Drug Administration.

I have published over 160 peer-reviewed articles, editorials, reviews, and book chapters. I have written extensively about methods for conducting economic assessments and estimated the value for the cost of therapies in areas such as mental health, weight loss, cardiovascular risk factors, major infections, cancer, stroke, heart failure, and nutritional support. Over the last 35 years, my major contributions in the field of health economics relate to the development and evaluation of methods for using patient-level data to conduct cost-effectiveness analyses of interventions in randomized trials. They have been synthesized in the first and second editions of the first book ever dedicated to this topic, Glick, et al., Economic Evaluation in Clinical Trials.

H Indices

ISI Core H Index: 46

Google Scholar H Index: 65

My Vita